James Badgett – Grants & Contracts — University of Kentucky

If you made any changes in Pure these will be visible here soon.

54 Active
76 Finished

50 - 54 out of 54 results

Filter

Active
A Phase III Randomized Trial for Patients with de novo AML Using Bortezomib and Sorafenib for Patients with High Allelic Ratio FLT3/ITD
Badgett, J., Radulescu, V. & Wagner, L.
Public Health Institute
3/31/17 → 5/2/24
Project: Research project
A Phase 2 Study of the JAK1/JAK2 Inhibitor Ruxolitinib with Chemotherapy in Children with De Novo High-Risk CRLLF2-Rearranged and/or JAK Pathway-Mutant Acute Lymphoblastic Leukemia AALL1521
Badgett, J., Radulescu, V. & Wagner, L.
Public Health Institute
12/1/16 → 1/25/24
Project: Research project
Sunshine Study Protocol MCC 18613 Phase II Study of nab-Paclitaxel in Combination with Gemcitabine for Treatment of Recurrent/Refractory Sarcoma in Teenagers and Young Adults
Badgett, J. & Wagner, L.
H Lee Moffitt Cancer Center and Research Institute Hospital
10/19/16 → 5/18/24
Project: Research project
NCTN BIQSFP AALL1131
Badgett, J., Radulescu, V. & Wagner, L.
Public Health Institute
3/1/16 → 1/12/24
Project: Research project

Your message has successfully been sent.

Your message was not sent due to an error.